Cargando…

Correction to: Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy

Detalles Bibliográficos
Autores principales: Mensali, Nadia, Myhre, Marit Renée, Dillard, Pierre, Pollmann, Sylvie, Gaudernack, Gustav, Kvalheim, Gunnar, Wälchli, Sébastien, Inderberg, Else Marit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6949204/
https://www.ncbi.nlm.nih.gov/pubmed/31776597
http://dx.doi.org/10.1007/s00262-019-02409-6
_version_ 1783485871401467904
author Mensali, Nadia
Myhre, Marit Renée
Dillard, Pierre
Pollmann, Sylvie
Gaudernack, Gustav
Kvalheim, Gunnar
Wälchli, Sébastien
Inderberg, Else Marit
author_facet Mensali, Nadia
Myhre, Marit Renée
Dillard, Pierre
Pollmann, Sylvie
Gaudernack, Gustav
Kvalheim, Gunnar
Wälchli, Sébastien
Inderberg, Else Marit
author_sort Mensali, Nadia
collection PubMed
description
format Online
Article
Text
id pubmed-6949204
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-69492042020-01-23 Correction to: Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy Mensali, Nadia Myhre, Marit Renée Dillard, Pierre Pollmann, Sylvie Gaudernack, Gustav Kvalheim, Gunnar Wälchli, Sébastien Inderberg, Else Marit Cancer Immunol Immunother Correction Springer Berlin Heidelberg 2019-11-27 2020 /pmc/articles/PMC6949204/ /pubmed/31776597 http://dx.doi.org/10.1007/s00262-019-02409-6 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Correction
Mensali, Nadia
Myhre, Marit Renée
Dillard, Pierre
Pollmann, Sylvie
Gaudernack, Gustav
Kvalheim, Gunnar
Wälchli, Sébastien
Inderberg, Else Marit
Correction to: Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy
title Correction to: Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy
title_full Correction to: Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy
title_fullStr Correction to: Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy
title_full_unstemmed Correction to: Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy
title_short Correction to: Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy
title_sort correction to: preclinical assessment of transiently tcr redirected t cells for solid tumour immunotherapy
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6949204/
https://www.ncbi.nlm.nih.gov/pubmed/31776597
http://dx.doi.org/10.1007/s00262-019-02409-6
work_keys_str_mv AT mensalinadia correctiontopreclinicalassessmentoftransientlytcrredirectedtcellsforsolidtumourimmunotherapy
AT myhremaritrenee correctiontopreclinicalassessmentoftransientlytcrredirectedtcellsforsolidtumourimmunotherapy
AT dillardpierre correctiontopreclinicalassessmentoftransientlytcrredirectedtcellsforsolidtumourimmunotherapy
AT pollmannsylvie correctiontopreclinicalassessmentoftransientlytcrredirectedtcellsforsolidtumourimmunotherapy
AT gaudernackgustav correctiontopreclinicalassessmentoftransientlytcrredirectedtcellsforsolidtumourimmunotherapy
AT kvalheimgunnar correctiontopreclinicalassessmentoftransientlytcrredirectedtcellsforsolidtumourimmunotherapy
AT walchlisebastien correctiontopreclinicalassessmentoftransientlytcrredirectedtcellsforsolidtumourimmunotherapy
AT inderbergelsemarit correctiontopreclinicalassessmentoftransientlytcrredirectedtcellsforsolidtumourimmunotherapy